Viatris Inc. Common Stock (VTRS) is a publicly traded Healthcare sector company. As of August 19, 2026, VTRS trades at $16.26 with a market cap of $18.64B and a P/E ratio of -45.49. VTRS moved -0.31% today. Year to date, VTRS is +29.88%; over the trailing twelve months it is +52.12%. Its 52-week range spans $6.85 to $18.39. Analyst consensus is neutral with an average price target of $18.17. Rallies surfaces VTRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for VTRS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $16.26 |
| Market Cap | $18.64B |
| P/E Ratio | -45.49 |
| EPS | $-0.36 |
| Dividend Yield | 0.12% |
| 52-Week High | $18.39 |
| 52-Week Low | $6.85 |
| Volume | 5.48M |
| Avg Volume | 0 |
| Revenue (TTM) | $14.74B |
| Net Income | $-410.70M |
| Gross Margin | 34.83% |
6 analysts cover VTRS: 0 strong buy, 2 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $18.17.